4th Quarter - Report
EXELIXIS INC. for EXELIXIS INC.
Firm
Client
Income
—
Expenses
$220,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
HR 3-Elijah E. Cummings Lower Drug Costs Now Act, S.2543-Prescription Drug Pricing Reduction Act of 2019, and other proposals related to drug pricing; and implementation of The Creating & Restoring Equal Access to Equivalent Samples ("CREATES") Act of 2019.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES M. FENTON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.